The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment

Bull N Y Acad Med. 1989 Jan;65(1):93-110.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Cytotoxicity, Immunologic
  • Drug Evaluation
  • Forecasting
  • Histocompatibility Antigens / immunology
  • Humans
  • Immunotherapy
  • Interleukin-2 / physiology
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Lymphokine-Activated / immunology
  • Lymphocyte Activation
  • Neoplasms / immunology
  • Neoplasms / therapy*

Substances

  • Histocompatibility Antigens
  • Interleukin-2